2020 № S5 Telemedicine technologies: prospects and limitations
In the context of rapid technological progress, the outlines of the prospects for the development of telemedicine
technologies are becoming more and more clear. At the same time, changes in the organizational, legal and economic spheres often do not keep up with technological changes. This was especially evident in the conditions of the spread of the COVID‑19 coronavirus.
The article contains an analysis of the features of telemedicine technologies application in modern conditions, prospects and obstacles that arise in this area.
2020 № 2 Legal problems of telemedicine technologies application in the context of fighting the spread of COVID-19 coronavirus
The purpose of the research is to analyze the legal problems of using telemedicine technologies, taking into account the experience of other countries; to assess the limitations of using telemedicine technologies in preventing the spread of COVID-19 coronavirus; to develop approaches to overcome existing restrictions in this area.
The authors consider the system of legal relations that arise between various participants in the provision of telemedicine services, focusing on international experience in this field.
On the example of the Russian Federation, the analysis of legal restrictions for the development of telemedicine technologies, which are typical for other countries, is carried out. A number of common problems of implementing telemedicine technologies are identified, as well as the specifics of legal regulation of telemedicine services in the Russian Federation.
Measures are proposed to overcome a number of legal restrictions in the use of telemedicine services related to licensing, labor legislation, etc.
2020 № 3 Economic aspects of providing medical care using telemedicine technologies
The aim of the research is to study the economic aspects of telemedicine technologies application, taking into account
the experience of other countries; to develop methodological approaches to evaluating the effectiveness of telemedicine technologies; to analyze the features of evaluating the effectiveness of telemedicine technologies in the conditions of COVID‑19 coronavirus spread. Methodological approaches to evaluating the effectiveness of telemedicine technologies are proposed.
The additional costs and benefits of using telemedicine technologies are analyzed in the context of the main participants: the state, medical organizations, doctors, and patients. The additional costs of introducing telemedicine technologies are estimated in terms of their belonging to the so-called “necessary costs” or investments that have different economic content . The proposals developed by the authors allow us to more correctly assess the effectiveness of investments in the provision of telemedicine services and, thus, choose the most optimal options.
2019 № 4 Tasks of distribution of medical appointmen
The statements and algorithms for solving problems on the formation of routes for medical examinations and treatment are discussed. The problems of the optimal route for an individual patient are considered taking into account the doctors’ work schedule and the distribution of appointments for a group of patients with the same and different medical care requirements
2020 № S5 Algorithms for solving problems of scheduling diagnostic and therapeutic measures in a medical information system
The statements and algorithms for solving the problem of scheduling medical examinations and treatment of patients
in a medical information system are considered. The problem of the optimal multi-day route for the provision of medical procedures to a patient is solved, taking into account the doctors’ work schedule. Cases of one- and multi-day service are considered. A description of the algorithms is given and their comparison is performed.
2020 № S5 Medical care information support in HIS in scope of clinical approbation
The Article is devoted to analyze the statutory acts on medical care in scope of clinical approbation, and information
support it in HIS.